PubMed Health⌕ Search

Biomedical subjects

O S Shkrob

Publications and source records attributed to O S Shkrob.

At least 55 records · Page 3Linked to original sources

[Splenectomy in the treatment of severe forms of myasthenia gravis].

The authors describe the results of clinical and electromyography examinations of 20 patients with grave generalized myasthenia, carried out within the short-term (up to 2 weeks) and long-term period (up to 1 year) after splenectomy. In these patients, the preceding therapy (thymectomy, gamma-therapy of the thymic area, the treatment with prednisolone, azathioprine, plasmapheresis, etc) had not produced any beneficial effect. The efficacy of splenectomy was assessed according to the Keens classification (A-E). In the short-term period after splenectomy the C effect was recorded in 13 out of the 20 patients. Out of 9 patients examined in the long-term period, the B effect was revealed in 3 patients, the C effect persisted in 3 patients, and 3 patients manifested the return to the initial status, namely to the E effect. Therefore in the group of patients with grave generalized myasthenia, the efficacy of splenectomy amounted to 65%. In view of this fact the inclusion of the given treatment method into the multimodality treatment of myasthenic patients is regarded advisable.

Adult↗

[Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)].

The authors discuss the results of splenectomy carried out on 20 patients with generalized myasthenia in whom previous complex treatment including thymectomy, corticosteroid and azathioprine therapy, repeated courses of plasmapheresis during medication with anticholinesterase agents, did not cause any essential improvement. Different values of homeostasis and immunological status were studied before and in different periods after splenectomy. The condition improved in 65% of patients, which was confirmed by the results of myography; the doses of corticosteroids and anticholinesterase agents were reduced. Bearing in mind the severe condition of patients selected for splenectomy, it is recommended to treat them only in medical centers possessing sufficient experience in treatment of myasthenia. The indications and contraindications for splenectomy in complex treatment of myasthenia must be specified further.

Adrenal Cortex Hormones↗

[Surgical interventions in concurrent and concomitant diseases in patients with myasthenia gravis].

The authors analyse the recent 15 years' results of treatment of 51 patients with generalized myasthenia who underwent operation in the clinic for various surgical diseases. Forty-three of them had a history of operation on the thymus. The specific features of preoperative management, anesthesia, and postoperative treatment in this serious category of patients are discussed. It is concluded that it is expedient to hospitalize these patients in special surgical hospitals possessing experience in the treatment of patients with generalized myasthenia and the possibility of conducting long-term ventilation of the lungs and other measures of resuscitation.

Adolescent↗

[Factors determining prognosis in stage T1.2NoMo breast cancer].

From study of data on 5- and 10-year survivals of 560 patients who underwent operation for breast cancer in stage T1.2NoMo, the authors determined the most significant prognostic factors. These were the histological form of the tumor and the degree of invasion into the adjoining tissues. The percentage of each studied factor was determined by mathematical analysis, which allowed the individual prognosis for each patient to be made and treatment planned accordingly.

Adult↗